Neuro‐oncological ventral antigen 1 (NOVA1): Implications in neurological diseases and cancers

Cell Proliferation - Tập 50 Số 4 - 2017
Yu Xin1, Zheng Li2, Heyi Zheng1, Jeffery Ho3, Matthew T.V. Chan3, William K.K. Wu3,4
1Department of Dermatology Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100042 China
2Department of Orthopedics Surgery Peking Union Medical College Hospital Chinese Academy of Medical Sciences and Peking Union Medical College Beijing 100042 China
3Department of Anaesthesia and Intensive Care, The Chinese University of Hong Kong, Hong Kong
4State Key Laboratory of Digestive Disease and LKS Institute of Health Sciences The Chinese University of Hong Kong Hong Kong

Tóm tắt

AbstractNeuro‐oncological ventral antigen 1 (NOVA1) is a RNA‐binding protein that interacts with RNA containing repeats of the YCAY sequence. This protein is a brain‐specific splicing factor regulating neuronal alternative splicing. It has been increasingly recognized as an important contributor to neurological disorders and carcinogenesis. In this review, we summarize the biological functions and pathological roles of NOVA1. The clinical implications of NOVA1 will also be discussed.

Từ khóa


Tài liệu tham khảo

10.1016/0896-6273(93)90077-5

10.1056/NEJMra023009

10.1126/science.1111443

10.1128/MCB.17.6.3194

10.1016/S0896-6273(00)80900-9

10.1016/S0092-8674(00)80668-6

10.1126/science.1090095

10.7554/eLife.14371

10.1073/pnas.95.22.13254

10.1016/0304-3940(93)90538-V

10.1038/nature09000

10.1523/JNEUROSCI.16-03-01114.1996

10.1016/j.bbagrm.2016.08.006

10.1186/s13039-016-0269-1

10.1369/0022155412461255

10.1242/dmm.025841

10.15252/embj.201490643

10.1186/s12885-015-1473-9

10.1371/journal.pone.0109124

10.18632/oncotarget.6542

Kim EK, 2016, Implications of NOVA1 suppression within the microenvironment of gastric cancer: association with immune cell dysregulation, Gastric Cancer

10.1016/j.febslet.2015.09.009

10.1371/journal.pone.0090955

10.1186/s12929-016-0288-6

10.4132/jptm.2016.02.08

10.1371/journal.pone.0081217

10.1093/nar/gku861